Does UPADACITINIB Cause Malignant melanoma? 152 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Malignant melanoma have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.
152
Reports of Malignant melanoma with UPADACITINIB
0.2%
of all UPADACITINIB reports
3
Deaths
7
Hospitalizations
How Dangerous Is Malignant melanoma From UPADACITINIB?
Of the 152 reports, 3 (2.0%) resulted in death, 7 (4.6%) required hospitalization, and 3 (2.0%) were considered life-threatening.
Is Malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 152 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Malignant melanoma?
SILDENAFIL (1,248)
ADALIMUMAB (795)
TADALAFIL (741)
ETANERCEPT (495)
INFLIXIMAB (478)
METHOTREXATE (475)
DABRAFENIB (402)
LENALIDOMIDE (378)
RANITIDINE (352)
RITUXIMAB (291)
Which UPADACITINIB Alternatives Have Lower Malignant melanoma Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL